Pfizer says FDA may pull its Covid vaccine for young childrennews2025-08-13T17:15:21+00:00August 13th, 2025|Endpoints News|
Autolus says it won’t make money from its cell therapy in Europe until 2027news2025-08-13T11:17:42+00:00August 13th, 2025|Endpoints News|
US tariffs could undo generic drugmakers’ efforts to be less reliant on Chinese raw materials, experts saynews2025-08-13T11:00:20+00:00August 13th, 2025|Endpoints News|
AbbVie announces $195M API plant outside of Chicagonews2025-08-12T19:39:20+00:00August 12th, 2025|Endpoints News|
Padcev-Keytruda combo shows ‘compelling’ survival results in bladder cancernews2025-08-12T18:42:04+00:00August 12th, 2025|Endpoints News|
Fertility startup Gameto raises $44M to fund Phase 3 study of stem cell IVF therapynews2025-08-12T18:02:55+00:00August 12th, 2025|Endpoints News|
Insmed gets FDA approval for the first DPP1 inhibitor, in lung diseasenews2025-08-12T17:01:25+00:00August 12th, 2025|Endpoints News|
Sanofi, Regeneron’s cholesterol drug is in short supply in Chinanews2025-08-12T14:04:43+00:00August 12th, 2025|Endpoints News|
Endpoints livestream: What RFK’s exile of mRNA says about MAHA and biotechnews2025-08-12T12:00:25+00:00August 12th, 2025|Endpoints News|
Vaxart receives second stop-work order for next-gen Covid vaccine news2025-08-11T20:13:56+00:00August 11th, 2025|Endpoints News|
